Rational Design of (Oxadiazol-2-yl) Thiazolidin-4-one Derivatives for Parkinson’s Disease: Insights from MD Simulations and Quantum Studies
- DOI
- 10.2174/0118715273437267251211144051
- Published
- 2026-04-29
- Container
- CNS & Neurological Disorders - Drug Targets
- Publisher
- Bentham Science Publishers Ltd.
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.2174/0118715273437267251211144051,
title = {Rational Design of (Oxadiazol-2-yl) Thiazolidin-4-one Derivatives for Parkinson’s Disease: Insights from MD Simulations and Quantum Studies},
author = {Asif Shaik and Krishna Shevate and Anik Sen and Shanish Antony A. and Gomathy Subramanian},
year = {2026},
journal = {CNS \& Neurological Disorders - Drug Targets},
doi = {10.2174/0118715273437267251211144051},
url = {https://doi.org/10.2174/0118715273437267251211144051}
}RIS
TY - JOUR TI - Rational Design of (Oxadiazol-2-yl) Thiazolidin-4-one Derivatives for Parkinson’s Disease: Insights from MD Simulations and Quantum Studies AU - Asif Shaik AU - Krishna Shevate AU - Anik Sen AU - Shanish Antony A. AU - Gomathy Subramanian PY - 2026 JO - CNS & Neurological Disorders - Drug Targets DO - 10.2174/0118715273437267251211144051 UR - https://doi.org/10.2174/0118715273437267251211144051 ER -
APA
Shaik, A., Shevate, K., Sen, A., A., S. A., & Subramanian, G. (2026). Rational Design of (Oxadiazol-2-yl) Thiazolidin-4-one Derivatives for Parkinson’s Disease: Insights from MD Simulations and Quantum Studies. CNS & Neurological Disorders - Drug Targets. https://doi.org/10.2174/0118715273437267251211144051
Source records
- crossref · retrieved 2026-09-27T00:06:24.586Z